SYMPTOMATIC DERMOGRAPHISM
Clinical trials for SYMPTOMATIC DERMOGRAPHISM explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC DERMOGRAPHISM trials appear
Sign up with your email to follow new studies for SYMPTOMATIC DERMOGRAPHISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could stop hives from scratching or cold
Disease control CompletedThis phase 2a trial tested an oral drug called EVO756 in 30 adults with chronic inducible urticaria, a condition where physical triggers like scratching or cold cause hives. The study aimed to see if the drug is safe and can reduce wheals. Results are not yet available.
Matched conditions: SYMPTOMATIC DERMOGRAPHISM
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New shot could tame stubborn hives that antihistamines Can't stop
Disease control CompletedThis Phase 2 study tested a drug called barzolvolimab (CDX-0159) in 196 adults with chronic inducible urticaria—hives triggered by cold or scratching—that persist despite antihistamines. Participants received either the drug or a placebo as a shot under the skin. The main goal wa…
Matched conditions: SYMPTOMATIC DERMOGRAPHISM
Phase: PHASE2 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC